Skip to main navigation Skip to search Skip to main content

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

  • David J. Inwards
  • , P. A. Fishkin
  • , B. R. LaPlant
  • , M. T. Drake
  • , P. J. Kurtin
  • , D. A. Nikcevich
  • , D. B. Wender
  • , B. S. Lair
  • , T. E. Witzig

Research output: Contribution to journal › Article › peer-review

19   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science